Termination of the business combination with Second Sight Medical Products, Inc.
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private...
Day: April 3, 2021
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
Qelbree (viloxazine extended-release capsules) represents the first novel non-stimulant treatment for ADHD in a decade Supernus plans to make Qelbree...
Termination of the business combination with Second Sight Medical Products, Inc.
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private...
DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors
Montrouge, France, April 2, 2021DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors DBV Technologies (Euronext: DBV...